Lab-on-a-chip methods for point-of-care measurements of salivary biomarkers of periodontitis

Annals of the New York Academy of Sciences

Volumn 1098, Issue , 2007, Pages 411-428

  Christodoulides, Nicolaos ^a   Floriano, Pierre N ^a   Miller, Craig S ^b,c   Ebersole, Jeffrey L ^b,c   Mohanty, Sanghamitra ^a   Dharshan, Priya ^a   Griffin, Michael ^a   Lennart, Alexis ^a   Ballard, Karri L Michael ^a   King Jr , Charles P ^b   Langub, M Chris ^c,d   Kryscio, Richard J ^e   Thomas, Mark V ^b   McDevitt, John T ^a,f  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b UNIVERSITY OF KENTUCKY COLLEGE OF DENTISTRY   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

^d NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^e UNIVERSITY OF KENTUCKY COLLEGE OF PUBLIC HEALTH   (United States)

^f The University of Texas at Austin   (United States)

Author keywords

Biomarkers; Inflammation; Lab on a chip; Periodontitis; Salivary diagnostics

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 1BETA; NEUTROPHIL COLLAGENASE; SILICON;

ADULT; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DIAGNOSTIC TEST; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LAB ON A CHIP; MALE; PERIODONTITIS; POINT OF CARE TESTING; PRINCIPAL COMPONENT ANALYSIS; SALIVA; SALIVA ANALYSIS; SALIVATION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; ARTICLE; CHEMISTRY; COMPARATIVE STUDY; ENZYMOLOGY; HOSPITAL INFORMATION SYSTEM; INSTRUMENTATION; METABOLISM; METHODOLOGY; MICROCHIP ANALYSIS;

BIOLOGICAL MARKERS; HUMANS; MICROCHIP ANALYTICAL PROCEDURES; PERIODONTITIS; POINT-OF-CARE SYSTEMS; PRINCIPAL COMPONENT ANALYSIS; SALIVA;

EID: 34248231248     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1384.035     Document Type: Conference Paper

References (54)

1. PETERSEN, P.E. & H. OGAWA. 2005. Strengthening the prevention of periodontal disease: the WHO approach. J. Periodontol. 76: 2187-2193.
2. HERRERA, D., S. ROLDAN & M. SANZ. 2000. The periodontal abscess: a review. J. Clin. Periodontol. 27: 377-386.
3. PIHLSTROM, B.L., B.S. MICHALOWICZ & N.W. JOHNSON. 2005. Periodontal diseases. Lancet 366: 1809-1820.
4. SOUTHERLAND, J.H., G.W. TAYLOR, K. MOSS, et al. 2006. Commonality in chronic inflammatory diseases: periodontitis, diabetes, and coronary artery disease. Periodontology 2000 40: 130-143.
5. KHADER, Y.S. & Q. TA'ANI. 2005. Periodontal diseases and the risk of preterm birth and low birth weight: a meta-analysis. J. Periodontol. 76: 161-165.
6. MATTILA, K.J., P.J. PUSSINEN & S. PAJU. 2005. Dental infections and cardiovascular diseases: a review. J. Periodontol. 76: 2085-2088.
7. OFFENBACHER, S. 2004. Maternal periodontal infections, prematurity, and growth restriction. Clin. Obstet. Gynecol. 47: 808-821.
8. AJWANI, S., K.J. MATTILA, T.O. NARHI, et al. 2003. Oral health status, C-reactive protein and mortality - a 10 year follow-up study. Gerodontology 20: 32-40.
9. MEURMAN, J.H., S.J. JANKET, M. QVARNSTROM & P. NUUTINEN. 2003. Dental infections and serum inflammatory markers in patients with and without severe heart disease. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 96: 695-700.
10. NOACK, B., R.J.GENCO, M. TREVISAN, et al. 2001. Periodontal infections contribute to elevated systemic C-reactive protein level. J. Periodontol. 72: 1221-1227.
11. WEHRMACHER, W.H. 2001. Periodontal disease predicts and possibly contributes to acute myocardial infarction. Dent. Today 20: 80-81.
12. LEVY, G. & R. LAMPMAN. 1975. Relationship between pH of saliva and pH of urine. J. Pharm. Sci. 64: 890-891.
13. THAYSEN, J.H., N.A. THORN & I.L. SCHWARTZ. 1954. Excretion of sodium, potassium, chloride and carbon dioxide in human parotid saliva. Am. J. Physiol. 178: 155-159.
14. BREIMER, D.D. & M. DANHOF. 1980. Saliva - fluid for measuring drug concentrations. Pharm. Int. 1: 9-11.
15. CADDY, B. 1984. In Advances in Analytical Toxicology, volume 1. R.C. Baselt, Ed.: 198-254. Biomedical Publications, Foster City, CA.
16. DANHOF, M. & D.D. BREIMER. 1978. Therapeutic drug monitoring in saliva. Clin. Pharmacokin. 3: 39-57.
17. DROBITCH, R.K. & C.K. SVENSSON. 1992. Therapeutic drug-monitoring in saliva - an update. Clin. Pharmacokinet. 23: 365-379.
18. GORODETZKY, C.W. & M.P. KULLBERG. 1974. Validity of screening methods for drugs of abuse in biological fluids. II. Heroin in plasma and saliva. Clin. Pharmacol. Ther. 15: 579-587.
19. IDOWU, O.R. & B. CADDY. 1982. A review of the use of saliva in the forensic detection of drugs and other chemicals. J. Forensic Sci. Soc. 22: 123-135.
20. SCHRAMM, W., R.H. SMITH, P.A. CRAIG & D.A. KIDWELL. 1992. Drugs of abuse in saliva - a review. J. Anal. Toxicol. 16: 1-9.
21. CHU, F.W. & R.P. EKINS. 1988. Detection of corticosteroid binding globulin in parotid fluids - evidence for the presence of both protein-bound and non-protein-bound (free) steroids in uncontaminated saliva. Acta Endocrinol. 119: 56-60.
22. DEBOEVER, J., F. KOHEN, J. BOUVE, et al. 1990. Direct chemiluminescence immunoassay of estradiol in saliva. Clin. Chem. 36: 2036-2041.
23. REY, F., G. CHIODONI, K. BRAILLARD, et al. 1990. Free testosterone levels in plasma and saliva as determined by a direct solid-phase radioimmunoassay - a critical evaluation. Clin. Chim. Acta 191: 21-30.
24. SELBY, C., P.A. LOBB & W.J. JEFFCOATE. 1988. Sex-hormone binding globulin in saliva. Clin. Endocrinol. 28: 19-24.
25. ARCHIBALD, D.W., L. ZON, J.E. GROOPMAN, et al. 1986. Antibodies to human T-lymphotropic virus type-Iii (Htlv-Iii) in saliva of acquired-immunodeficiency-syndrome (AIDS) patients and in persons at risk for AIDS. Blood 67: 831-834.
26. GRAU, A.J., A.W. BODDY, D.A. DUKOVIC, et al. 2004. Leukocyte count as an independent predictor of recurrent ischemic events. Stroke 35: 1147-1152.
27. SKIDMORE, S.J. & C.A. MORRIS. 1992. Salivary testing for HIV infection. Br. Med. J. 305: 1094.
28. KAUFMAN, E. & I.B. LAMSTER. 2000. Analysis of saliva for periodontal diagnosis - a review. J. Clin. Periodontol. 27: 453-465.
29. KLOCK, B., M. SVANBERG & L.G. PETERSSON. 1990. Dental-caries, mutans streptococci, lactobacilli, and saliva secretion rate in adults. Commun. Dent. Oral Epidemiol. 18: 249-252.
30. KOHLER, B. & S. BJARNASON. 1992. Mutans streptococci, lactobacilli and caries prevalence in 15- to 16-year olds in Goteborg. 2. Swed. Dent. J. 16: 253-259.
31. EL-NAGGAR, A.K., L. MAO, G. STAERKEL, et al. 2001. Genetic heterogeneity in saliva from patients with oral squamous carcinomas - implications in molecular diagnosis and screening. J. Mol. Diagn. 3: 164-170.
32. LIAO, P.H., Y.C. CHANG, M.F. HUANG, et al. 2000. Mutation of p53 gene codon 63 in saliva as a molecular marker for oral squamous cell carcinomas. Oral Oncol. 36: 272-276.
33. MERCER, D.K., K.P. SCOTT, C.M. MELVILLE, et al. 2001. Transformation of an oral bacterium via chromosomal integration of free DNA in the presence of human saliva. FEMS Microbiol. Lett. 200: 163-167.
34. STAMEY, F.R., M. DELEON-CARNES, M.M. PATEL, et al. 2003. Comparison of a microtiter plate system to Southern blot for detection of human herpesvirus 8 DNA amplified from blood and saliva. J. Virol. Methods 108: 189-193.
35. CHRISTODOULIDES, N., M. TRAN, P.N. FLORIANO, et al. 2002. A microchip-based multianalyte assay system for the assessment of cardiac risk. Anal. Chem. 74: 3030-3036.
36. CUREY, T.E., A. GOODEY, A. TSAO, et al. 2001. Characterization of multicomponent monosaccharide solutions using an enzyme-based sensor array. Anal. Biochem. 293: 178-184.
37. GOODEY, A., J.J. LAVIGNE, S.M. SAVOY, et al. 2001. Development of multianalyte sensor arrays composed of chemically derivatized polymeric microspheres localized in micromachined cavities. J. Am. Chem. Soc. 123: 2559-2570.
38. GOODEY, A.P. & J.T. MCDEVITT. 2003. Multishell microspheres with integrated chromatographic and detection layers for use in array sensors. J. Am. Chem. Soc. 125: 2870-2871.
39. LAVIGNE, J.J., S. SAVOY, M.B. CLEVENGER, et al. 1998. Solution-based analysis of multiple analytes by a sensor array: toward the development of an "electronic tongue." J. Am. Chem. Soc. 120: 6429-6430.
40. MCCLESKEY, S.C., M.J. GRIFFIN, S.E. SCHNEIDER, et al. 2003. Differential receptors create patterns diagnostic for ATP and GTP. J. Am. Chem. Soc. 125: 1114-1115.
41. MCCLESKEY, S.C., P.N. FLORIANO, S.L. WISKUR, et al. 2003. Citrate and calcium determination in flavored vodkas using artificial neural networks. Tetrahedron 59: 10089-10092.
42. WISKUR, S.L., P.N. FLORIANO, E.V. ANSLYN & J.T. MCDEVITT, 2003. A multicomponent sensing ensemble in solution: differentiation between structurally similar analytes. Angewandte Chemie International Edition 42: 2070-2072.
43. ALI, M.F., R. KIRBY, A.P. GOODEY, et al. 2003. DNA hybridization and discrimination of single-nucleotide mismatches using chip-based microbead arrays. Anal. Chem. 75: 4732-4739.
44. CHRISTODOULIDES, N., P.N. FLORIANO, S.A. ACOSTA, et al. 2005. Towards the development of a lab-on-a-chip dual function white blood cell and C-reactive protein analysis method for the assessment of inflammation and cardiac risk. Clin. Chem. 51: 2391-2395.
45. LI, S., P.N. FLORIANO, N. CHRISTODOULIDES, et al. 2005. Disposable polydimethylsiloxane/ silicon hybrid chips for protein detection. Biosens. Bioelectron. 21: 574-580.
46. CHRISTODOULIDES, N., S. MOHANTY, C.S. MILLER, et al. 2005. Application of microchip assay system for the measurement of C-reactive protein in human saliva. Lab Chip 5: 261-269.
47. LI, S., D. FOZDAR, M.F. ALI, et al. 2005. A continuous flow polymerasse chain reaction microchip with regional velocity control. J. Microelectromech. Syst. 15: 223-236.
48. NAVAZESH, M. 1993. Methods for collecting saliva. Ann. N. Y. Acad. Sci. 694: 72-77.
49. MILLER, C.S., C.P. KING, C. LANGUB, et al. 2006. Salivary biomarkers of existing periodontal disease - A cross-sectional study. J. Am. Dent. Assoc. 137: 322-329.
50. VITZTHUM, F., F. BEHRENS, N.L. ANDERSON & J.H. SHAW. 2005. Proteomics: from basic research to diagnostic application. A review of requirements and needs. J. Proteome Res. 4: 1086-1097.
51. DIEHL, S.R., T.X. WU, B.S. MICHALOWICZ, et al. 2005. Quantitative measures of aggressive periodontitis show substantial heritability and consistency with traditional diagnoses. J. Periodontol. 76: 279-288.
52. ASSUMA, R., T. OATES, D. COCHRAN, et al. 1998. IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis. J. Immunol. 160: 403-409.
53. DELIMA, A.J., S. KARATZAS, S. AMAR & D.T. GRAVES. 2002. Inflammation and tissue loss caused by periodontal pathogens is reduced by interleukin-1 antagonists. J. Infect. Dis. 186: 511-516.
54. GRAVES, D.T., A.J. DELIMA, R. ASSUMA, et al. 1998. Interleukin-1 and tumor necrosis factor antagonists inhibit the progression of inflammatory cell infiltration toward alveolar bone in experimental periodontitis. J. Periodontol. 69: 1419-1425.